ABOUT THIS EPISODE
In this episode of The Connect Current, host James Zanewicz sits down with Ivana Mikić, PhD, CEO of Sarpeda Inc., to explore how AI is helping researchers unlock more value from the biological imaging tools they already use.
Ivana shares how Sarpeda is using AI-powered software to improve fluorescence microscopy, reduce imaging challenges, and extract more biological information from existing research workflows. The conversation explores why better imaging matters for scientific discovery, what practical AI looks like in life sciences, and how researchers can gain deeper insights without costly infrastructure changes.
As one of Connect's 2026 Cool Companies, Sarpeda represents a new generation of startups applying advanced technology to real-world scientific challenges. This episode offers a look at the intersection of AI, biology, commercialization, and the future of research innovation.
Ivana shares how Sarpeda is using AI-powered software to improve fluorescence microscopy, reduce imaging challenges, and extract more biological information from existing research workflows. The conversation explores why better imaging matters for scientific discovery, what practical AI looks like in life sciences, and how researchers can gain deeper insights without costly infrastructure changes.
As one of Connect's 2026 Cool Companies, Sarpeda represents a new generation of startups applying advanced technology to real-world scientific challenges. This episode offers a look at the intersection of AI, biology, commercialization, and the future of research innovation.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of The Connect Current.
OTHER EPISODES IN THIS PODCAST
In this episode of The Connect Current, we sit down with James Mackay, Ph.D., President and CEO of Crystalys Therapeutics, to explore how the company is advancing a new treatment path for people living with gout. James shares how Crystalys is developing dotinurad, a next-generation, once-daily oral…
In this episode of The Connect Current, we sit down with Stanley Lewis, MD, MPH, Founder and CEO of A28 Therapeutics, to explore how targeted cancer therapies can create better options for patients facing difficult diseases. Stanley shares the story behind A28’s targeted oncolytic peptide platform,…
In this episode of The Connect Current, we sit down with Scott Tait to explore how San Diego can better connect national security needs, university research, dual-use startups, capital, and policy into a stronger innovation system. Drawing on his 27-year Navy career and his work across Lumetec, Sta…
In this episode of The Connect Current, we sit down with Niren Shah, PharmD, MBA, Co-founder and CEO of Cove Therapeutics, to explore one of the biggest challenges in genetic medicine: delivery. Niren shares how Cove is developing non-lipid, non-viral biodegradable polymeric nanoparticles designed …
In this episode of The Connect Current, we sit down with Ramesh Ramji, Founder and CEO of SpectralTx, to explore how spectral hyperplexing technology could help reshape molecular screening and the future of connected data. Ramesh shares how SpectralTx is developing tools like Spectra-Gel and SpELs …
Disclaimer: The podcast and artwork embedded on this page are from Connect, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
